$BHE earnings report

Benchmark delivers record third quarter revenue and strong earnings growth; raises fiscal year 2026 outlook. AlphAI read Benchmark Electronics's Third quarter 2026 filing as strong. 2 quarters are on record below.

Third quarter 2026

AlphAI · Earnings readBHE · Third quarter 2026 · ended September 30, 2026

Benchmark delivers record third quarter revenue and strong earnings growth; raises fiscal year 2026 outlook.

✓Strong quarter

Third-quarter revenue was $811 million, up 19% year-over-year, while diluted GAAP EPS rose 21% and diluted non-GAAP EPS rose 35%. The company also raised its fiscal-year revenue-growth outlook to approximately 16%.

Revenue
$811M
up 19% year-over-year y/y
Semi-Cap
$ 241
Gross margin · GAAP
10.4 %
EPS · non-GAAP
$0.84
up 35% year-over-year y/y
Fourth Quarter 2026 outlook
between $815 million and $855 million

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Revenue, three months ended September 30, 2026GAAP$811M–up 19% year-over-year
Gross profit, three months ended September 30, 2026GAAP$84.45M––
Gross margin, three months ended September 30, 2026GAAP10.4 %––
Operating income, three months ended September 30, 2026GAAP$ 30,699––
Operating margin, three months ended September 30, 2026GAAP3.8 %––
Net income, three months ended September 30, 2026GAAP$17.15M––
Basic earnings per share, three months ended September 30, 2026GAAP$ 0.48––
Diluted earnings per share, three months ended September 30, 2026GAAP$0.47–up 21% year-over-year
Non-GAAP income from operations, three months ended September 30, 2026non-GAAP$44.71M––
Non-GAAP operating margin, three months ended September 30, 2026non-GAAP5.5 %––
Non-GAAP gross profit, three months ended September 30, 2026non-GAAP$84.94M––
Non-GAAP gross margin, three months ended September 30, 2026non-GAAP10.5 %––
Non-GAAP net income, three months ended September 30, 2026non-GAAP$30.70M––
Diluted earnings per share, three months ended September 30, 2026non-GAAP$0.84–up 35% year-over-year
Operating cash flow, three months ended September 30, 2026GAAP$ 29,912––
Additions to property, plant and equipment and software, three months ended September 30, 2026GAAP−$15.48M––
Free cash flow, three months ended September 30, 2026non-GAAP$14.44M––
Revenue, nine months ended September 30, 2026GAAP$ 2,244,158––
Gross profit, nine months ended September 30, 2026GAAP$232.1M––
Gross margin, nine months ended September 30, 2026GAAP10.3 %––
Income from operations, nine months ended September 30, 2026GAAP$82.83M––
Operating margin, nine months ended September 30, 2026GAAP3.7 %––
Net income, nine months ended September 30, 2026GAAP$50.05M––
Diluted earnings per share, nine months ended September 30, 2026GAAP$ 1.38––
Non-GAAP income from operations, nine months ended September 30, 2026non-GAAP$116.0M––
Non-GAAP operating margin, nine months ended September 30, 2026non-GAAP5.2 %––
Non-GAAP net income, nine months ended September 30, 2026non-GAAP$79.14M––
Diluted earnings per share, nine months ended September 30, 2026non-GAAP$ 2.18––
Net cash provided by operating activities, nine months ended September 30, 2026GAAP$111.6M––
Free cash flow, nine months ended September 30, 2026non-GAAP$64.95M––

Segments

SegmentRevenueq/qy/y
Semi-Cap30 % of total revenue.$ 241––
Industrial21 % of total revenue.$ 172––
Medical17 % of total revenue.$ 138––
AC&C16 % of total revenue.$ 132––
A&D16 % of total revenue.$ 128––

Fourth Quarter 2026 outlook

  • Revenuebetween $815 million and $855 million
  • NoteDiluted GAAP earnings per share between $0.58 and $0.64
  • NoteDiluted non-GAAP earnings per share between $0.85 and $0.91
  • NoteDiluted non-GAAP earnings per share guidance excludes stock-based compensation expense of approximately $7.8 million and other non-operating expenses of $2.7 million to $3.2 million, which includes restructuring, amortization of intangibles and other expenses
  • NoteFiscal year 2026 revenue growth of approximately 16%

Capital returns

  • Share repurchases of $ (14,266 ) during the nine months ended September 30, 2026.

What drove it

  • Management said demand is broadening across the portfolio and bookings momentum remains healthy.
  • Semi-Cap was the largest sector at $ 241, representing 30 % of total revenue.
  • Third-quarter non-GAAP operating margin was 5.5 %, compared with 4.8 % in the prior-year quarter and 5.2 % in the second quarter of 2026.
  • The company raised its outlook and now expects 2026 revenue growth of approximately 16%.

Concerns

  • Third-quarter GAAP operating margin was 3.8 %, below the 4.0 % reported in the second quarter of 2026.
  • Third-quarter operating cash flow of $ 29,912 and free cash flow of $ 14,435 were below $ 36,608 and $ 25,114, respectively, in the prior-year quarter.
  • Inventories increased to $ 633,575 at September 30, 2026 from $ 482,544 at December 31, 2025.
  • The filing identifies risks from customer-demand fluctuations, supply-chain constraints, inflationary pressures, foreign-currency fluctuations, high interest rates, geopolitical uncertainty, tariffs, facility utilization, and obsolete or unsold inventory.

What to watch

  • Fourth-quarter revenue delivery against guidance of between $815 million and $855 million.
  • Fourth-quarter diluted GAAP earnings per share guidance of between $0.58 and $0.64 and diluted non-GAAP earnings per share guidance of between $0.85 and $0.91.
  • Whether the company sustains its 5.5 % third-quarter non-GAAP operating margin.
  • Inventory levels, which were $ 633,575 at September 30, 2026.
  • Cash conversion cycle performance following 54 days in the third quarter of 2026.

Balance sheet and cash flow

  • Cash and cash equivalents were $ 290,656 at September 30, 2026, compared with $ 322,064 at December 31, 2025.
  • Current installments of long-term debt were $ 3,750 at September 30, 2026, unchanged from $ 3,750 at December 31, 2025.
  • Long-term debt, net of current installments, was $ 154,086 at September 30, 2026, compared with $ 206,826 at December 31, 2025.
  • Inventories were $ 633,575 at September 30, 2026, compared with $ 482,544 at December 31, 2025.
  • Accounts receivable, net, were $ 435,296 at September 30, 2026, compared with $ 391,101 at December 31, 2025.
  • Accounts payable were $ 663,708 at September 30, 2026, compared with $ 403,222 at December 31, 2025.
  • Cash conversion cycle was 54 days in the third quarter of 2026, compared with 77 days in the third quarter of 2025 and 59 days in the second quarter of 2026.
  • Net cash used in investing activities was $ (44,387 ) during the nine months ended September 30, 2026.
  • Net cash used in financing activities was $ (94,808 ) during the nine months ended September 30, 2026.
  • Net debt activity was $ (53,175 ) during the nine months ended September 30, 2026.

Analysis

Benchmark reported record third-quarter revenue of $811 million, up 19% year-over-year from $681 million and above $756 million in the second quarter. Management described demand as broadening across its portfolio and said bookings momentum remained healthy. Semi-Cap was the largest reported sector at $241 million, or 30% of total revenue, followed by Industrial at $172 million, Medical at $138 million, AC&C at $132 million, and A&D at $128 million.

Profitability expanded materially from the prior-year quarter. GAAP gross margin was 10.4%, compared with 10.0%, while GAAP operating margin was 3.8%, compared with 3.5%. Non-GAAP gross margin was 10.5%, compared with 10.1%, and non-GAAP operating margin was 5.5%, compared with 4.8%. GAAP diluted EPS of $0.47 increased 21% year-over-year, while non-GAAP diluted EPS of $0.84 increased 35% year-over-year. Sequentially, GAAP operating margin was below 4.0% in the second quarter, but non-GAAP operating margin increased from 5.2%.

Cash generation was positive but lower than the prior-year quarter. Third-quarter operating cash flow was $29,912 and free cash flow was $14,435, versus $36,608 and $25,114, respectively, in the prior-year quarter. For the nine-month period, net cash provided by operating activities was $111,615 and free cash flow was $64,946. Cash and cash equivalents were $290,656 at September 30, 2026, while long-term debt, net of current installments, was $154,086. The company repurchased $14,266 of shares during the nine months ended September 30, 2026.

Working-capital deployment bears attention. Inventories were $633,575 at September 30, 2026, compared with $482,544 at December 31, 2025, while accounts payable increased to $663,708 from $403,222. The cash conversion cycle improved to 54 days from 77 days in the prior-year quarter and 59 days in the second quarter. Management guided fourth-quarter revenue to between $815 million and $855 million and raised its fiscal-year expectation to revenue growth of approximately 16%.

The fourth-quarter EPS ranges call for diluted GAAP EPS between $0.58 and $0.64 and diluted non-GAAP EPS between $0.85 and $0.91. The filing states that non-GAAP guidance excludes approximately $7.8 million of stock-based compensation expense and $2.7 million to $3.2 million of other non-operating expenses, including restructuring, amortization of intangibles and other expenses. Execution against this revenue and earnings outlook, margin retention, inventory management, and continued cash conversion are the principal reported items to monitor.

Management, verbatim

Our third quarter results reflect the continued transformation of Benchmark into a higher-performing company.

David Moezidis, President and CEO

Demand is broadening across our portfolio, bookings momentum remains healthy, and our teams continue to execute at a high level. As a result, we delivered record quarterly revenue, grew earnings at nearly twice the rate of sales, and are once again raising our outlook for the year. We now expect 2026 revenue growth of approximately 16%, further increasing our outlook beyond the $3 billion annual revenue level we established last quarter.

David Moezidis, President and CEO

Not in the filing

stated, not guessed
  • Previous-release outlook was not provided, so comparisons of actual results with prior guidance are unavailable.
  • Fourth-quarter gross-margin guidance was not provided.
  • Fourth-quarter operating-expense guidance was not provided.
  • Fourth-quarter tax-rate guidance was not provided.
  • A quantitative bookings figure was not provided.
  • A quarterly share-repurchase amount was not provided.
  • Dividend amount or dividend guidance was not provided.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

second quarter 2026

AlphAI · Earnings readBHE · second quarter 2026 · ended June 30, 2026

BENCHMARK REPORTS STRONG SECOND QUARTER RESULTS RAISES FISCAL 2026 REVENUE GUIDANCE TO A RECORD $3 BILLION

✓Strong quarter

Revenue was $756 million, up 18% year-over-year, while diluted non-GAAP earnings per share was $0.75, up 36% year-over-year. GAAP and non-GAAP operating margins reached 4.0% and 5.2%, respectively, and the company raised its fiscal 2026 revenue outlook to approximately $3 billion.

Revenue
$756M
up 18% year-over-year y/y
Semi-Cap
$223M
Gross margin · GAAP
10.4 %
EPS · non-GAAP
$0.75
up 36% year-over-year y/y
Third Quarter 2026 and fiscal year 2026 outlook
Third Quarter 2026: between $755 million and $795 million. Fiscal year 2026: revenue growth of approximately 13%, positioning Benchmark to achieve $3 billion in annual revenue.

Key metrics

shortened, hover for the filing’s print
MetricValueq/qy/y
Revenue, three months ended June 30, 2026GAAP$756M–up 18% year-over-year
Gross margin, three months ended June 30, 2026GAAP10.4 %––
Operating margin, three months ended June 30, 2026GAAP4.0 %––
Diluted EPS, three months ended June 30, 2026GAAP$0.55––
Gross margin, three months ended June 30, 2026non-GAAP10.5 %––
Operating margin, three months ended June 30, 2026non-GAAP5.2 %––
Diluted EPS, three months ended June 30, 2026non-GAAP$0.75–up 36% year-over-year
Sales, three months ended June 30, 2026GAAP$756.0M––
Cost of sales, three months ended June 30, 2026GAAP677.6M––
Gross profit, three months ended June 30, 2026GAAP78.4M––
Selling, general and administrative expenses, three months ended June 30, 2026GAAP46.13M––
Amortization of intangible assets, three months ended June 30, 2026GAAP1.20M––
Restructuring charges and other costs, three months ended June 30, 2026GAAP811K––
Income from operations, three months ended June 30, 2026GAAP30.25M––
Interest expense, three months ended June 30, 2026GAAP−3.75M––
Interest income, three months ended June 30, 2026GAAP1.99M––
Other income, net, three months ended June 30, 2026GAAP223K––
Income before income taxes, three months ended June 30, 2026GAAP28.71M––
Income tax expense, three months ended June 30, 2026GAAP8.83M––
Net income, three months ended June 30, 2026GAAP$19.88M––
Basic EPS, three months ended June 30, 2026GAAP$ 0.55––
Sales, six months ended June 30, 2026GAAP$1.43B––
Gross profit, six months ended June 30, 2026GAAP147.6M––
Income from operations, six months ended June 30, 2026GAAP52.13M––
Net income, six months ended June 30, 2026GAAP$32.91M––
Diluted EPS, six months ended June 30, 2026GAAP$ 0.91––
Operating cash flow, second quarter 2026GAAP$35M––
Free cash flow, second quarter 2026non-GAAP$22M––
Cash conversion cycle, three months ended June 30, 2026other59 days––
Days in accounts receivable, three months ended June 30, 2026other54––
Days in contract asset, three months ended June 30, 2026other23––
Days in inventory, three months ended June 30, 2026other72––
Days in accounts payable, three months ended June 30, 2026other(73 )––
Days in advance payments from customers, three months ended June 30, 2026other(17 )––

Segments

SegmentRevenueq/qy/y
Semi-CapNo sector-specific driver was disclosed.$223M––
IndustrialNo sector-specific driver was disclosed.$161M––
A&DNo sector-specific driver was disclosed.$111M––
MedicalNo sector-specific driver was disclosed.$134M––
AC&CNo sector-specific driver was disclosed.$127M––

Third Quarter 2026 and fiscal year 2026 outlook

  • RevenueThird Quarter 2026: between $755 million and $795 million. Fiscal year 2026: revenue growth of approximately 13%, positioning Benchmark to achieve $3 billion in annual revenue.
  • NoteThird Quarter 2026 diluted GAAP earnings per share between $0.51 and $0.57.
  • NoteThird Quarter 2026 diluted non-GAAP earnings per share between $0.76 and $0.82.
  • NoteNon-GAAP earnings per share guidance excludes stock-based compensation expense of approximately $8.4 million and other non-operating expenses of $3.5 million to $4.0 million, which includes restructuring, amortization of intangibles and other expenses.

What drove it

  • Revenue of $756 million was up 18% year-over-year.
  • Management cited continued momentum, another record quarter of bookings, strengthening demand across end markets, growing customer engagement, and disciplined execution.
  • Semi-Cap revenue was $ 223 million, Industrial revenue was $ 161 million, Medical revenue was $ 134 million, and AC&C revenue was $ 127 million in the second quarter 2026.
  • GAAP gross margin was 10.4 % and non-GAAP gross margin was 10.5 %.
  • The company raised its full-year outlook and expects revenue growth of approximately 13%.

Concerns

  • A&D revenue was $ 111 million in the second quarter 2026, compared with $ 126 million in the three months ended June 30, 2025 and $ 120 million in the three months ended March 31, 2026.
  • Days in accounts receivable were 54 in the second quarter 2026, compared with 50 in the three months ended March 31, 2026.
  • Accounts receivable, net was 451,612 (in thousands) and inventories were 544,261 (in thousands) at June 30, 2026.
  • The filing identifies risks including customer demand fluctuations, supply chain constraints, inflationary pressures, foreign currency fluctuations, high interest rates, geopolitical uncertainties, tariffs, manufacturing-facility utilization, and inventory write-downs or write-offs.

What to watch

  • Third-quarter revenue delivery within the guidance range of between $755 million and $795 million.
  • Third-quarter diluted GAAP earnings per share guidance of between $0.51 and $0.57 and diluted non-GAAP earnings per share guidance of between $0.76 and $0.82.
  • Execution toward fiscal 2026 revenue growth of approximately 13% and $3 billion in annual revenue.
  • Sustainability of the 10.4 % GAAP gross margin and 5.2 % non-GAAP operating margin.
  • Bookings, end-market demand, accounts receivable days, inventory, and the 59-day cash conversion cycle.

Balance sheet and cash flow

  • Cash and cash equivalents were $ 314,836 (in thousands) at June 30, 2026, compared with $ 322,064 (in thousands) at December 31, 2025.
  • Restricted cash was 377 (in thousands) at June 30, 2026, compared with 336 (in thousands) at December 31, 2025.
  • Accounts receivable, net was 451,612 (in thousands) at June 30, 2026, compared with 391,101 (in thousands) at December 31, 2025.
  • Contract assets were 196,420 (in thousands) at June 30, 2026, compared with 182,870 (in thousands) at December 31, 2025.
  • Inventories were 544,261 (in thousands) at June 30, 2026, compared with 482,544 (in thousands) at December 31, 2025.
  • Property, plant and equipment, net was 232,856 (in thousands) at June 30, 2026, compared with 223,784 (in thousands) at December 31, 2025.
  • Current installments of long-term debt were $ 3,750 (in thousands) at June 30, 2026, unchanged from December 31, 2025.
  • Long-term debt, net of current installments was 177,234 (in thousands) at June 30, 2026, compared with 206,826 (in thousands) at December 31, 2025.
  • Total assets were $ 2,214,371 (in thousands) at June 30, 2026, compared with $ 2,071,715 (in thousands) at December 31, 2025.
  • Total liabilities were 1,098,088 (in thousands) at June 30, 2026, compared with 971,912 (in thousands) at December 31, 2025.
  • Shareholders’ equity was 1,116,283 (in thousands) at June 30, 2026, compared with 1,099,803 (in thousands) at December 31, 2025.
  • Operating cash flow was $35 million and free cash flow was $22 million in the second quarter 2026.

Analysis

Benchmark reported second-quarter revenue of $756 million, up 18% year-over-year from $642 million and above the $677 million reported in the three months ended March 31, 2026. The company described the quarter as another record period of bookings and attributed the result to strengthening end-market demand, customer engagement, and execution. Sector revenue was led by Semi-Cap at $223 million, followed by Industrial at $161 million, Medical at $134 million, AC&C at $127 million, and A&D at $111 million.

Profitability improved across the reported summary measures. GAAP gross margin was 10.4 %, compared with 10.1 % in the three months ended June 30, 2025 and 10.2 % in the three months ended March 31, 2026. GAAP operating margin was 4.0 %, versus 3.2 % in both comparison periods. Non-GAAP gross margin reached 10.5 % and non-GAAP operating margin reached 5.2 %. GAAP diluted EPS was $0.55, while non-GAAP diluted EPS was $0.75, up 36% year-over-year.

Cash generation was positive, with operating cash flow of $35 million and free cash flow of $22 million in the second quarter. The cash conversion cycle was 59 days, compared with 85 days in the three months ended June 30, 2025 and 67 days in the three months ended March 31, 2026. At June 30, 2026, cash and cash equivalents were $ 314,836 (in thousands), while long-term debt, net of current installments, was 177,234 (in thousands). Accounts receivable, net and inventories were 451,612 (in thousands) and 544,261 (in thousands), respectively.

The company guided third-quarter revenue to between $755 million and $795 million, with diluted GAAP EPS between $0.51 and $0.57 and diluted non-GAAP EPS between $0.76 and $0.82. It also raised fiscal 2026 revenue expectations to growth of approximately 13%, positioning the company to achieve $3 billion in annual revenue. The most notable portfolio contrast is A&D at $111 million, compared with $126 million in the three months ended June 30, 2025 and $120 million in the three months ended March 31, 2026, while Semi-Cap, Industrial, Medical, and AC&C each reported higher revenue than in the three months ended March 31, 2026.

Management, verbatim

Our second quarter results reflect continued momentum across the business, highlighted by revenue and earnings above the high end of our prior guidance along with another record quarter of bookings.

David Moezidis, Benchmark’s President and CEO

Strengthening demand across our end markets, growing customer engagement, and disciplined execution are contributing to broad ‑ based improvement throughout the portfolio. As a result, we are again raising our full year outlook and now expect revenue growth of approximately 13%, positioning Benchmark to achieve $3 billion in annual revenue for the first time in the company’s history.

David Moezidis, Benchmark’s President and CEO

Not in the filing

stated, not guessed
  • Previous-release outlook was not provided, so comparison of actual results with prior guidance is unavailable.
  • No capital-return amounts for share repurchases or dividends were reported in the provided filing text.
  • No third-quarter gross-margin, operating-expense, or tax-rate guidance was reported.
  • No fiscal 2026 GAAP or non-GAAP EPS guidance was reported.
  • The provided cash-flow statement text is truncated; complete six-month cash-flow line items, capital expenditures, and a cash-flow reconciliation to free cash flow were not available.
  • No sector-specific revenue growth percentages or sector-specific demand drivers were reported.
  • No GAAP tax rate was reported.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about BHE earnings dates

When is Benchmark Electronics's next earnings date?
AlphAI has no date for BHE yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.